IP Library › Patent Application 17013987
Patent Application
App. No. 17/013,987

USE OF AMISULPRIDE AS AN ANTI-EMETIC

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/013,987
Abstract

Amisulpride is used in the therapy of nausea, vomiting or retches. The therapy may utilize a novel injectable formulation, in unit dosage form, comprising less than 50 mg amisulpride.

Claims (2)

1 . A pharmaceutical composition comprising amisulpride in an amount of less than 50 mg per dose, and a pharmaceutically acceptable carrier.

2 . A method for the prevention and/or treatment of post-operative nausea and vomiting, comprising administering amisulpride at a dose of less than 50 mg to a subject in need thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2026
From: ACACIA PHARMA LIMITED; ACACIA PHARMA, INC.; EAGLE PHARMACEUTICALS, INC.
To: LXO IRELAND DESIGNATED ACTIVITY COMPANY; LXO US, INC.
Reel/Frame 073967/0303 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2020
From: GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; COOPER, NICOLA; FOX, GABRIEL
To: ACACIA PHARMA LIMITED
Reel/Frame 053709/0626 →